NCT03305159View on ClinicalTrials.gov

Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

April 1, 2018

Study Completion Date

April 15, 2018

Conditions
Surgical Preparation of the Vagina
Interventions
DRUG

Povidone-Iodine

Patients will receive povidone iodine for the surgical preparation of the vagina.

DRUG

4% Chlorhexidine Gluconate

Patients will receive 4% chlorhexidine gluconate for the surgical preparation of the vagina.

Trial Locations (1)

60611

Prentice Women's Hospital - Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03305159 - Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution | Biotech Hunter | Biotech Hunter